Aptevo Therapeutics Change To Netincome Over Time

APVO Stock  USD 3.26  0.19  5.51%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Aptevo Therapeutics Performance and Aptevo Therapeutics Correlation.
To learn how to invest in Aptevo Stock, please use our How to Invest in Aptevo Therapeutics guide.
  
As of the 20th of February 2025, Change To Netincome is likely to grow to about (27.4 M).
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptevo Therapeutics. If investors know Aptevo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptevo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(87.38)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.76)
Return On Equity
(2.84)
The market value of Aptevo Therapeutics is measured differently than its book value, which is the value of Aptevo that is recorded on the company's balance sheet. Investors also form their own opinion of Aptevo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aptevo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptevo Therapeutics' market value can be influenced by many factors that don't directly affect Aptevo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptevo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptevo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptevo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Change To Netincome Analysis

Compare Aptevo Therapeutics and related stocks such as Kronos Bio, Cyclerion Therapeutics, and Larimar Therapeutics Change To Netincome Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
2010201120122013201420152016201720182019202020212022202320242025
KRON99 K99 K99 K99 K99 K99 K99 K99 K99 K403 K39.3 M26.7 M32.2 M32.2 M37 M21.7 M
CYCN7.2 M7.2 M7.2 M7.2 M7.2 M7.2 M7.2 M9.5 M12.4 M20.4 M15.2 M13.2 M6.3 M6.3 M7.2 M13.2 M
LRMR173 K173 K173 K173 K173 K173 K173 K173 K173 K129 K2.2 M5.5 M6.6 M6.6 M7.6 MM
ADXN0.00.00.00.00.01.6 M235 K1.1 M2.7 M2.3 M2.1 M1.1 M3.9 M3.9 M4.5 M4.7 M
ACHL76 K76 K76 K76 K76 K76 K76 K76 K76 K724 K4.2 M6.5 M13.9 M13.9 M16 M16.8 M
NTRB7.8 K7.8 K7.8 K7.8 K7.8 K7.8 K7.8 K2.5 M1.8 M955.3 KM3.5 M1.3 M1.3 M1.5 M1.7 M
QNRX378.3 K378.3 K378.3 K378.3 K378.3 K378.3 K378.3 K378.3 K378.3 K378.3 K378.3 K14 M891.1 K891.1 KM973.5 K
LGVN423.9 K423.9 K423.9 K423.9 K423.9 K423.9 K423.9 K423.9 K423.9 K136.8 K82.8 KM2.6 M2.6 MM2.5 M
RNXT46 K46 K46 K46 K46 K46 K46 K46 K46 K46 K50 K(33 K)(33 K)(33 K)(29.7 K)(28.2 K)
VRAX62.6 K62.6 K62.6 K62.6 K62.6 K62.6 K62.6 K62.6 K62.6 K62.6 K1.2 K255.4 K1.5 M1.5 M1.7 M1.8 M
PASG2.7 M2.7 M2.7 M2.7 M2.7 M2.7 M2.7 M2.7 M2.7 M11.5 M14.6 M32.7 M19 M19 M21.8 M17.7 M
IVVD68.7 M68.7 M68.7 M68.7 M68.7 M68.7 M68.7 M68.7 M68.7 M68.7 M68.7 M19.3 M39 M39 M35.1 M33.9 M
ATXI3.4 M3.4 M3.4 M3.4 M3.4 M3.4 M340 K3.2 M1.5 M1.8 M710 K442 K(4.5 M)(4.5 M)(4 M)(3.8 M)
HOTH2.3 M2.3 M2.3 M2.3 M2.3 M2.3 M2.3 M2.3 M143.1 K2.5 M1.2 M1.7 M1.7 M1.7 M1.5 M1.2 M
REVBMMMMMMMM4.7 M43.8 K43.8 K(1 M)(1 M)(1 M)(914.9 K)(869.1 K)
JavaScript chart by amCharts 3.21.15Macroaxis Charts2012201420162018202020222024 10M20M30M40M50M60M
JavaScript chart by amCharts 3.21.15Kronos Biototal: 190.4MCyclerion Therapeuticstotal: 153.9MLarimar Therapeuticstotal: 38.2MAchilles Therapeutics PLCtotal: 72.6MNutribandtotal: 16.7MQuoin Pharmaceuticals Ltdtotal: 22MLongeveron LLCtotal: 22.9MVirax Biolabs Grouptotal: 7.2MPassage Biototal: 160.8MInvivydtotal: 921.9MHoth Therapeuticstotal: 29.7M

Aptevo Therapeutics and related stocks such as Kronos Bio, Cyclerion Therapeutics, and Larimar Therapeutics Change To Netincome description

My Equities

My Current Equities and Potential Positions

Aptevo Therapeutics
APVO
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationWashington; U.S.A
ExchangeNASDAQ Exchange
USD 3.1
When determining whether Aptevo Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aptevo Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aptevo Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aptevo Therapeutics Stock:
Check out Aptevo Therapeutics Performance and Aptevo Therapeutics Correlation.
To learn how to invest in Aptevo Stock, please use our How to Invest in Aptevo Therapeutics guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Aptevo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Aptevo Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Aptevo Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...